To find out whether GCN2-eIF2α-ATF4-CHOP pathway was activated in HCT116 tumor cells deprived of glutamine, cells were incubated in glutamine-free medium in the presence or absence of the GCN2 inhibitor A92 [20]. This evidence concerns the gene DDIT3 and neoplasm.